New drug combo aims to shrink liver tumors before surgeons operate
NCT ID NCT04658147
Summary
This early-stage study is testing whether giving one or two immunotherapy drugs before and after surgery is safe and helpful for people with liver cancer that can be removed. The goal is to see if the drugs shrink the tumor before surgery and help prevent the cancer from coming back afterward. Researchers will track 31 patients to measure side effects, surgery success, and long-term survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, 21231, United States
-
The Ohio State University, Wexner Medical Center
Columbus, Ohio, 43210-1002, United States
Conditions
Explore the condition pages connected to this study.